Berman Capital Advisors’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$26K Buy
128
+57
+80% +$12.2K ﹤0.01% 900
2021
Q2
$14K Buy
71
+2
+3% +$403 ﹤0.01% 1034
2021
Q1
$13K Hold
69
﹤0.01% 946
2020
Q4
$13K Buy
69
+10
+17% +$1.87K ﹤0.01% 829
2020
Q3
$10K Hold
59
﹤0.01% 801
2020
Q2
$9K Hold
59
﹤0.01% 811
2020
Q1
$8K Hold
59
﹤0.01% 741
2019
Q4
$9K Hold
59
﹤0.01% 792
2019
Q3
$8K Hold
59
﹤0.01% 796
2019
Q2
$8K Hold
59
﹤0.01% 824
2019
Q1
$7K Buy
59
+29
+97% +$3.41K ﹤0.01% 788
2018
Q4
$3K Buy
+30
New +$3.35K ﹤0.01% 817

Other funds holding STE

Berman Capital Advisors's STE Position: Q3 2021 in Review

Berman Capital Advisors increased its Steris (STE) stake by 80% in Q3 2021, buying an estimated $12.2K and bringing the position to 128 shares worth $26K. The position accounts for ﹤0.01% of the portfolio, ranked #900.

Berman Capital Advisors first reported a position in STE in Q4 2018 and has held it in 12 quarters since. 629 funds tracked by Wall St. Rank hold STE as of Q3 2021.

  • Berman Capital Advisors held 128 shares of Steris worth $26K as of Q3 2021.
  • Berman Capital Advisors bought 57 Steris shares in Q3 2021, an estimated $12.2K.
  • Steris made up ﹤0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #900 holding.
  • Berman Capital Advisors first reported a position in Steris in Q4 2018 and has held it in 12 quarters since.
  • 629 funds tracked by Wall St. Rank held Steris as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.